文献速递妇科

分子比较揭示子宫癌肉瘤与乳头状浆液性癌的转录组差异可通过DNA损伤区分

Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage.
PubMed 文献 · Gynecol Oncol · 2025-07-23

本研究对53例子宫乳头状浆液性癌(UPSC)和43例子宫癌肉瘤(UCS)的FFPE样本进行DNA损伤分析,发现UCS的DNA修复能力较UPSC增加3.6倍(p<0.0001),转录组分析证实UCS中DNA修复基因表达升高,而UPSC中DNA修复基因表达降低但未修复DNA损伤量约为UCS的4倍,且UPSC免疫激活同时伴免疫逃逸和免疫耗竭标志物升高,提示UPSC的免疫耗竭分子景观可能更适合免疫治疗,而DNA修复稳健的UCS可能对PARP抑制剂等靶向DNA修复的药物更敏感。

要点

  • UCS样本DNA修复能力较UPSC增加3.6倍(p<0.0001),转录组证实UCS中DNA修复基因表达升高。
  • UPSC中DNA修复基因表达降低,但未修复DNA损伤量约为UCS的4倍,伴免疫激活及免疫逃逸、免疫耗竭标志物升高。
  • 作者认为UPSC的免疫耗竭分子景观可能更适合免疫治疗,而DNA修复稳健的UCS可能对PARP抑制剂等靶向DNA修复药物更敏感。

核心结论

  • UPSC和UCS在DNA损伤修复和免疫转录组景观上存在显著差异,UPSC的免疫耗竭分子景观可能更适合免疫治疗,而DNA修复稳健的UCS可能对靶向DNA修复的药物如PARP抑制剂更敏感。
  • 通过RADD评估DNA修复能力可能具有与分子测序相当的治疗信息价值。

研究设计与样本

  • 研究纳入了本机构收集的53例UPSC和43例UCS的FFPE样本,使用修复辅助损伤检测(RADD)分析总DNA损伤。
  • 对部分患者样本进行RNA提取,并使用Nanostring nCounter PanCancer IO 360 panel分析基因表达。

主要发现

  • UCS样本的DNA修复能力较UPSC增加3.6倍(p<0.0001)。
  • 转录分析证实UCS中DNA修复基因表达升高。
  • UPSC中DNA修复基因表达降低,但未修复DNA损伤量约为UCS的4倍。
  • UPSC中免疫系统被激活,免疫细胞标志物水平升高,同时免疫逃逸基因和免疫耗竭标志物表达也增加。

临床怎么用

  • 作者认为UPSC的免疫耗竭分子景观可能更适合免疫治疗,而DNA修复稳健的UCS可能对PARP抑制剂等靶向DNA修复的药物更敏感。
  • 作者认为通过RADD评估DNA修复能力可能具有与分子测序相当的治疗信息价值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The role of mismatch repair deficiency (MMRd) or DNA damage & response (DDR) mechanisms in general are under-explored in rare endometrial cancer subtypes. We therefore sought to characterize the immune, inflammatory, and DNA damage profiles of uterine papillary serous carcinoma (UPSC) and uterine carcinosarcoma (UCS) to better define the role of immunotherapy (IO) in these tumors. METHODS: Total DNA damage was analyzed in 53 UPSC and 43 UCS FFPE samples collected at our institution using repair-assisted damage-detection (RADD). RNA was isolated from a subset of patients and expression was analyzed using the Nanostring nCounter PanCancer IO 360 panel. RESULTS: A 3.6-fold increase (p < 0.0001) in DNA repair capacity was seen in UCS samples compared to UPSC. Transcriptional analysis confirmed increased expression of DNA repair genes in UCS. Decreased expression of DNA repair genes was noted in UPSC despite nearly 4 times the amount of unrepaired DNA damage. As expected, the immune system was activated in response to this increased DNA damage with higher levels of markers of immune cells noted. However, there was also increased expression of immune evasive genes and markers of immune exhaustion. This suggests DNA damage tolerance and immune exhaustion are hallmarks of UPSC. CONCLUSIONS: We present here a detailed, treatment-oriented molecular comparison between two histologically distinct endometrial cancer subtypes, UPSC and UCS. Assessment of unrepaired DNA damage and, by proxy, DNA repair capacity, gives context to the immune transcriptomic landscape. Our data suggests that the immune exhausted molecular landscape of UPSC may be more amenable to IO than that of UCS, while the DNA repair-robust UCS may be more vulnerable to agents targeting DNA Damage repair such as PARP inhibitors. Further, our data suggests that estimation of DNA repair capacity via RADD may be as treatment informative as molecular sequencing.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lee KJ, Chokshi S, Joshi T, et al. Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage. Gynecol Oncol. 2025. PMID: 40706253. doi:10.1016/j.ygyno.2025.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。